26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies

Robert Nelson, Mark Ballow

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppresslve therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
Volume111
Issue number2 SUPPL. 2
StatePublished - Feb 1 2003

Fingerprint

Cytokine Receptors
Immunomodulation
Immunotherapy
Cytokines
Antibodies
Immunophilins
Pharmaceutical Preparations
Antimetabolites
Immunologic Factors
Virus Diseases
Immunization
Intercellular Signaling Peptides and Proteins
Chronic Disease
Therapeutics
Radiation
Population
Neoplasms

Keywords

  • Autoimmunity
  • Biological response modifiers
  • Cytokines
  • Glucocorticosteroids
  • Immunodeficiency
  • Immunomodulation
  • Immunophilins
  • Immunosuppressive
  • Monoclonal antibodies
  • Transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

26. Immunomodulation and immunotherapy : Drugs, cytokines, cytokine receptors, and antibodies. / Nelson, Robert; Ballow, Mark.

In: Journal of Allergy and Clinical Immunology, Vol. 111, No. 2 SUPPL. 2, 01.02.2003.

Research output: Contribution to journalReview article

@article{76cd6c6d10424978a6ab8603c7724bd6,
title = "26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies",
abstract = "The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppresslve therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.",
keywords = "Autoimmunity, Biological response modifiers, Cytokines, Glucocorticosteroids, Immunodeficiency, Immunomodulation, Immunophilins, Immunosuppressive, Monoclonal antibodies, Transplantation",
author = "Robert Nelson and Mark Ballow",
year = "2003",
month = "2",
day = "1",
language = "English (US)",
volume = "111",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2 SUPPL. 2",

}

TY - JOUR

T1 - 26. Immunomodulation and immunotherapy

T2 - Drugs, cytokines, cytokine receptors, and antibodies

AU - Nelson, Robert

AU - Ballow, Mark

PY - 2003/2/1

Y1 - 2003/2/1

N2 - The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppresslve therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.

AB - The preceding chapters in this primer have provided an overview of the immune response that serves as a background for understanding potential sites for immune modulation and immunotherapy. A number of soluble growth and activation factors are released from various cell populations involved in the immune response. They play vital roles in the initiation, propagation, and regulation of immunologic responses. Pharmacologic immunomodulators include suppressive and stimulatory agents. Immunosuppresslve therapies include antimetabolites, cytotoxic drugs, radiation, adrenocortical glucocorticosteroids, immunophilins, and therapeutic antibodies The field of clinical immunostimulation is emerging as an important therapeutic modality for a number of immunodeficiency diseases, chronic viral infections, and cancer. These compounds will be discussed in terms of general principles, molecular targets, major indications, and adverse effects.

KW - Autoimmunity

KW - Biological response modifiers

KW - Cytokines

KW - Glucocorticosteroids

KW - Immunodeficiency

KW - Immunomodulation

KW - Immunophilins

KW - Immunosuppressive

KW - Monoclonal antibodies

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0037323642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037323642&partnerID=8YFLogxK

M3 - Review article

C2 - 12592317

AN - SCOPUS:0037323642

VL - 111

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2 SUPPL. 2

ER -